Journal of Psychopharmacology

SCIE-ISI SCOPUS (1987-2023)

  1461-7285

  0269-8811

  Anh Quốc

Cơ quản chủ quản:  SAGE Publications Ltd

Lĩnh vực:
Psychiatry and Mental HealthMedicine (miscellaneous)Pharmacology (medical)Pharmacology

Các bài báo tiêu biểu

Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
Tập 30 Số 6 - Trang 495-553 - 2016
GM Goodwin, Peter Haddad, I. Nicol Ferrier, J K Aronson, Thomas Re Barnes, Andrea Cipriani, David Coghill, Seena Fazel, John Geddes, Heinz Grunze, Emily A. Holmes, Oliver Howes, Stephen M. Hudson, Neil Hunt, Ian Jones, Ian C. MacMillan, R. Hamish McAllister‐Williams, DavidJ. Miklowitz, Richard Morriss, Marcus R. Munafò, Carol Paton, Barbara J. Sahakian, Kate Saunders, Julia Sinclair, David Taylor, Eduard Vieta, Allan H. Young
The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder. The third version is based explicitly on the available evidence and presented, like previous Clinical Practice Guidelines, as recommendations to aid clinical decision making for practitioners: it may also serve as a source of information for patients and carers, and a...... hiện toàn bộ
5-HT and mechanisms of defence
Tập 5 Số 4 - Trang 305-315 - 1991
J.F.W. Deakin, Frederico Guilherme Graeff
Review: Suicide and schizophrenia: a systematic review of rates and risk factors
Tập 24 Số 4_suppl - Trang 81-90 - 2010
Kahyee Hor, Mark Taylor
Risk assessment is a core skill in psychiatry. Risk prediction for suicide in schizophrenia is known to be complex. We undertook a systematic review of all original studies concerning suicide in schizophrenia published since 2004. We found 51 data-containing studies (from 1281 studies screened) that met our inclusion criteria, and ranked these by standardized quality criteria. Estimates of...... hiện toàn bộ
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
Tập 19 Số 6 - Trang 567-596 - 2005
David S. Baldwin, Ian Anderson, David Nutt, Borwin Bandelow, Alyson J. Bond, Jonathan Davidson, Johan A. den Boer, Naomi Fineberg, Martín Knapp, Jan Scott, Hans‐Ulrich Wïttchen
These British Association for Psychopharmacology guidelines cover the range and aims of treatment for anxiety disorders. They are based explicitly on the available evidence and are presented as recommendations to aid clinical decision making in primary and secondary medical care. They may also serve as a source of information for patients and their carers. The recommendations are presente...... hiện toàn bộ
Hướng dẫn dựa trên bằng chứng cho việc điều trị rối loạn trầm cảm bằng thuốc chống trầm cảm: Sửa đổi hướng dẫn của Hiệp hội Tâm thần học Anh năm 2000 Dịch bởi AI
Tập 22 Số 4 - Trang 343-396 - 2008
Ian Anderson, I. Nicol Ferrier, Baldwin Rc, Philip J. Cowen, Louise M. Howard, Glyn Lewis, K. Matthews, R. Hamish McAllister‐Williams, R.C. Peveler, Jan Scott, André Tylee
Một cuộc sửa đổi hướng dẫn dựa trên bằng chứng của Hiệp hội Tâm thần học Anh năm 2000 về việc điều trị các rối loạn trầm cảm bằng thuốc chống trầm cảm đã được thực hiện để kết hợp các bằng chứng mới và cập nhật các khuyến nghị khi cần thiết. Một cuộc họp đồng thuận với sự tham gia của các chuyên gia về rối loạn trầm cảm và quản lý của chúng đã được tổ chức vào tháng 5 năm 2006. Các lĩnh v...... hiện toàn bộ
#Hướng dẫn #Rối loạn trầm cảm #Thuốc chống trầm cảm #Bằng chứng lâm sàng #Điều trị #Tái phát
Review: Glutamate and dopamine dysregulation in schizophrenia — a synthesis and selective review
Tập 21 Số 4 - Trang 440-452 - 2007
James Stone, Paul D. Morrison, Lyn S. Pilowsky
The dopamine hypothesis of schizophrenia is the principal explanatory model of antipsychotic drug action. Recent discoveries extend our understanding of the neurochemistry of schizophrenia, with increasing evidence of dysfunction in glutamate and GABA as well as dopamine systems. In this review, we study the evidence for dopaminergic dysfunction in schizophrenia, drawing data from neuroch...... hiện toàn bộ
A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use
Tập 12 Số 1 - Trang 54-67 - 1998
G. Di Chiara
The effects of drugs and substances of abuse on central dopamine (DA) transmission studied by in vivo monitoring techniques have been examined and compared with those of conventional reinforcers and in particular with food. The similarities and differences in the action of drugs and conventional reinforcers on DA transmission can provide the basis for an hypothesis of the mechanism of dru...... hiện toàn bộ
Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents
Tập 14 Số 2 - Trang 114-138 - 2000
Mark J. Millan, Françoise Lejeune, Alain P. Gobert
The frontal cortex (FCX) plays a key role in processes that control mood, cognition and motor behaviour, functions which are compromised in depression, schizophrenia and other psychiatric disorders. In this regard, there is considerable evidence that a perturbation of monoaminergic input to the FCX is involved in the pathogenesis of these states. Correspondingly, the modulation of monoami...... hiện toàn bộ
Is craving the source of compulsive drug use?
Tập 12 Số 1 - Trang 23-30 - 1998
Stephen T. Tiffany, Brian L. Carter
Compulsive drug use, which is typically portrayed as a defining quality of addictive behavior, has been described as a pattern of drug consumption that is stimulus bound, stereotyped, difficult to regulate and identified by a loss of control over intake. It is widely assumed that compulsive drug use is caused by drug craving. This assumption is supported by numerous findings of a general ...... hiện toàn bộ
Instability of the ecstasy market and a new kid on the block: mephedrone
Tập 25 Số 11 - Trang 1543-1547 - 2011
Tibor M. Brunt, Anneke Poortman, Raymond Niesink, Wim van den Brink
Recently, several reports have indicated instability of the ecstasy market in the Netherlands and other EU countries. In the current study, we demonstrate this instability in the Netherlands, showing a decrease of ecstasy tablets containing 3,4-methylenedioxymetamphetamine (MDMA) by more than 50% in 2009. In addition, we describe a partial replacement of MDMA in tablets sold as ecstasy by...... hiện toàn bộ